Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HemoCava: TachoSil in Liver Transplantation
NCT06124209Phase 4Recruiting
- Sponsor
- Medical University of Warsaw
- Start
- Nov 2023
- Primary completion
- Dec 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of tachosil in postoperative hemorrhage, sponsored by Medical University of Warsaw. Started Nov 2023; status: recruiting.
02
Drugs
tachosil
03
Conditions
postoperative hemorrhage
Beyond the preview
Go deeper on NCT06124209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06124209.